It is suggested that the increased production of S1P is probably a novel mechanism for chronic kidney damage in this hypertensive model and manipulating SphK1/S1P pathway may be used as novel strategies in the development of therapeutic approaches for chronic kidney diseases associated with hypertension. The gene discussed is MBTPS1; the disease is Hypertension.